Proteomic profiling of muscle invasive bladder cancer treated with neoadjuvant chemotherapy

Proteomic profiling of muscle invasive bladder cancer treated with neoadjuvant chemotherapy

Bibliographic Details
Main Authors:	A. Contreras-Sanz, M.J. Reike, G.L. Negri, H.Z. Oo, S. Spencer Miko, K. Nielsen, M.E. Roberts, J. Scurll, K. Ikeda, G. Wang, R. Seiler, G.B. Morin, P. Black
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168323000356

Similar Items

Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy
by: A. Contreras-Sanz, et al.
Published: (2025-02-01)

Author Correction: Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy
by: A. Contreras-Sanz, et al.
Published: (2025-02-01)

21 FBXW7 loss-of-function is associated with worse overall survival and leads to the accumulation of MYC in muscle-invasive bladder cancer
by: P. Black, et al.
Published: (2025-01-01)

Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future
by: Hermans, TJN, et al.
Published: (2017)

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

Neoadjuvant chemotherapy for bladder cancer: Two decades on
by: Rishi Nayyar
Published: (2025-01-01)

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
by: Arthur Peyrottes, et al.
Published: (2021-07-01)

Research Progress of Neoadjuvant Chemotherapy in Advanced Bladder Cancer
by: Haijun Hu, et al.
Published: (2024-09-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01)

Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions
by: N. G. Cowan, et al.
Published: (2014-01-01)

Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
by: Filipe LF. Carvalho, et al.
Published: (2020-07-01)

DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)
by: O.O. Sherstyuk, et al.
Published: (2022-08-01)

Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma
by: Daniel Herchenhorn, et al.
Published: (2007-12-01)

Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
by: Wolfgang Beckabir, et al.
Published: (2024-05-01)

CKD-EPI and cockcroft-gault equations identify similar candidates for neoadjuvant chemotherapy in muscle-invasive bladder cancer.
by: Sumanta K Pal, et al.
Published: (2014-01-01)

Complete regress of a low-differentiated recurrence of the bladder cancer as the answer on two cycles of neoadjuvant polychemotherapy
by: P. G. Yakovlev, et al.
Published: (2020-05-01)

Effects of Neoadjuvant Chemotherapy on Rates of Depression in Muscle Invasive Bladder Cancer
by: Matthew DeSanto, et al.
Published: (2024-07-01)

NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)

Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
by: Serhat Sekmek, et al.
Published: (2023-11-01)

An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer
by: Evanguelos Xylinas, et al.
Published: (2016-09-01)

Downstaging guided neoadjuvant strategy shift and bladder preservation in locally advanced bladder cancer: A case report
by: Gan Du, et al.
Published: (2024-03-01)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
by: Hyun Hwan Sung, et al.
Published: (2022-03-01)

Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: Results of an international consortium
by: M. Marchioni, et al.
Published: (2020-07-01)

Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer
by: Ekamjit S. Deol, et al.
Published: (2024-11-01)

Metabolic Profiling of Bladder Cancer Patients’ Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy
by: Juntao Zhuang, et al.
Published: (2022-06-01)

Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer
by: Hualin Chen, et al.
Published: (2022-08-01)

Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?
by: Nabil Ismaili, et al.
Published: (2011-09-01)

Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments
by: Giandomenico Roviello, et al.
Published: (2022-07-01)

Clinical Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy on Muscle-invasive Bladder Cancer
by: DENG Kangli, et al.
Published: (2019-04-01)

Systemic treatment for invasive bladder cancer: neoadjuvant chemotherapy and laparoscopic radical cystectomy
by: Eric Barret, et al.
Published: (2008-08-01)

The "responsibility to prevent": an international crimes approach to the prevention of mass atrocities
by: Reike, R
Published: (2014)

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
by: David D'Andrea, et al.
Published: (2022-07-01)

A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer
by: Davide Tortora, et al.
Published: (2023-05-01)

A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends, collaborations, and future avenues
by: Yi Huang, et al.
Published: (2024-02-01)

Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer
by: Bryce Baird, et al.
Published: (2023-08-01)

Neoadjuvant chemotherapy versus cystectomy in management of stages II, and III urinary bladder cancer
by: Mohammed A. Osman, et al.
Published: (2014-12-01)

Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes
by: Dellis A, et al.
Published: (2021-07-01)

Effectiveness of Neoadjuvant and Adjuvant Bladder Intracavitary Hyperthermic Perfusion Chemotherapy (BHPC) on High-risk Non-muscle-invasive Bladder Cancer Patients
by: LIU Sanhe, et al.
Published: (2019-03-01)

A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer
by: Chinna Babu Dracham, et al.
Published: (2022-07-01)

Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
by: Elizabeth A Guancial, et al.
Published: (2016-01-01)